Do you want to participate in our clinical trials?
EquiCord is committed to the research and development of new advanced therapy drugs that offer a long-term solution to veterinarians. Thanks to their potent anti-inflammatory and immunomodulatory action, mesenchymal cells have proven to be an effective and safe treatment for numerous pathologies, with a long-lasting effect after a single administration.
Inflammatory bowel disease (IBD) is a chronic, severe and debilitating disease with a mortality rate of over 30%. It is characterised by vomiting, diarrhoea, weight loss, weakness and reduced quality of life.
Until now IBD has been managed with high doses of immunosuppressants which have serious side effects.